Nonnucleoside reverse transcriptase inhibitors

Details Nonnucleoside reverse transcriptase inhibitors Nonnucleoside reverse transcriptase inhibitors

2007-07-10

2007-07-10

Saeed, Kamal A. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C548S370100

Reexamination Certificate

active

10781373

ABSTRACT:
This invention relates to novel pyrazole derivatives of formula I wherein R1 to R4 are as defined in the summary and pharmaceutically acceptable salts and solvates thereof, methods to inhibit or modulate Human Immunodeficiency Virus (HIV) reverse transcriptase with compounds of formula I and pharmaceutical compositions containing of formula I admixed with at least one solvent, carrier or excipient. The compounds are useful for treating disorders in which HIV and genetically related viruses are implicated

REFERENCES:
patent: 6538015 (2003-03-01), Dymock et al.
patent: 7109228 (2006-09-01), Jones et al.
patent: 2002/0032184 (2002-03-01), Corbau et al.
patent: 2002/0107272 (2002-08-01), Dymock et al.
patent: 2003/0008841 (2003-01-01), Devos et al.
patent: 2003/0018197 (2003-01-01), Dymock et al.
patent: 0 786 455 (1997-07-01), None
patent: WO 02/04424 (2002-01-01), None
patent: WO 02/30907 (2002-04-01), None
patent: WO 02/085860 (2002-10-01), None
patent: WO 02/100853 (2002-12-01), None

Affiliated with

Also associated with

Rating

Nonnucleoside reverse transcriptase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nonnucleoside reverse transcriptase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nonnucleoside reverse transcriptase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3736394